<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02272348</url>
  </required_header>
  <id_info>
    <org_study_id>9372</org_study_id>
    <nct_id>NCT02272348</nct_id>
  </id_info>
  <brief_title>Self-management of Type 1 Diabetes Under Functional Insulin Therapy</brief_title>
  <acronym>EVAUTODIAB</acronym>
  <official_title>Evaluation of Self-management of Patients With Type 1 Diabetes After Education to Functional Insulin Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Therapeutic education of patients is a mandatory component of intensive insulin therapy of&#xD;
      type 1 diabetes in order to reach optimal safety and efficacy. Used educational methods aim&#xD;
      at facilitating patients' autonomy in their own management of diabetes. Therefore,&#xD;
      self-management of patient with type 1 diabetes must be systematically assessed in order to&#xD;
      evaluate the effectiveness of education programs .The main objective of this prospective&#xD;
      controlled randomized monocentric study is to assess the impact of functional insulin therapy&#xD;
      on the level of self-management of patients with type 1 diabetes via Confidence In Diabetes&#xD;
      Self-care scale (CIDS) test.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      170 patients with type 1 diabetes, volunteering for education to functional insulin therapy,&#xD;
      will be recruited by the Department od Endocrinology, Diabetes, Nutrition of Montpellier&#xD;
      University Hospital.&#xD;
&#xD;
      After inclusion, the patients will be randomized in 2 groups: group 1 will be immediately&#xD;
      trained to functional insulin therapy and group 2 will be trained at the end of the study.&#xD;
      The patients will be met as outpatients 3 months after inclusion. The primary endpoint will&#xD;
      be the global score for CIDS questionnaire.&#xD;
&#xD;
      Secondary endpoints will include: HbA1c level at month 3, frequency of hypoglycemia from&#xD;
      inclusion to month 3, scores for each of the 20 items of CIDS questionnaire.&#xD;
&#xD;
      An ancillary study will assess: the acceptability of the new EAD questionnaire which&#xD;
      specifically evaluates the self-management of diabetes, the concordance validity of EAD and&#xD;
      CDIS questionnaires, the reproducibility test-retest, the internal consistency and the&#xD;
      sensitivity to change of EAD questionnaire.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Change in methodology too important - end of randomization&#xD;
  </why_stopped>
  <start_date type="Actual">February 10, 2015</start_date>
  <completion_date type="Actual">January 18, 2016</completion_date>
  <primary_completion_date type="Actual">January 18, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To assess the impact of therapeutic education by functional insulin therapy in patients with type 1 diabetes on their ability to disease self-management.</measure>
    <time_frame>three months (from inclusion until end of study)</time_frame>
    <description>CIDS questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To assess the effect of education to functional insulin therapy on HbA1c level</measure>
    <time_frame>three months (from inclusion until end of study)</time_frame>
    <description>HbA1c</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To assess the effect of education to functional insulin therapy on hypoglycemia frequency</measure>
    <time_frame>three months (from inclusion until end of study)</time_frame>
    <description>Hypoglycemia occurrence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To assess the effect of education to functional insulinotherapy on the score of each of the 20 items of CIDS questioonaire</measure>
    <time_frame>three months (from inclusion until end of study)</time_frame>
    <description>CIDS questionnaire sub scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To assess the validity, the concordance and the sensitivity to change of EAD questionnaire (specific for self-management of diabetes) in comparison with CIDS test</measure>
    <time_frame>three months (from inclusion until end of study)</time_frame>
    <description>EAD questionnaire score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Type 1 Diabetes</condition>
  <condition>Basal-bolus Multiple-dily Insulin Injections</condition>
  <condition>Insulin Pump (CSII)</condition>
  <arm_group>
    <arm_group_label>Education to functional insulin therapy immediately</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Immediately after inclusion, patients will follow a functional insulin therapy training course during 2.5 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No education to functional insulin therapy immediately</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>After inclusion in the study, patients go on usual diabetes management. At the end of study, they will receive education to functional insulin therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Training course to functional insulin therapy</intervention_name>
    <description>Carbohydrate counting, carbohydrate/insulin ratio, sensitivity to insulin factor</description>
    <arm_group_label>Education to functional insulin therapy immediately</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual diabetes management.</intervention_name>
    <arm_group_label>No education to functional insulin therapy immediately</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Type 1 diabetes from at least 1 year&#xD;
&#xD;
          -  Age from 18 to 70 (70 not included)&#xD;
&#xD;
          -  Basal-bolus multiple-dily insulin injections or insulin pump (CSII)&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
          -  Affiliated or benefit from an insurance regimen&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Type 2 diabetes&#xD;
&#xD;
          -  Unable to make mathematic calculation&#xD;
&#xD;
          -  Pregnancy, breast-feeding or absence of effective contraception&#xD;
&#xD;
          -  Psychiatric and/or cognitive status uncompatible with study&#xD;
&#xD;
          -  Eating disorders&#xD;
&#xD;
          -  Law protected person, vulnerable person&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elise DUTERTRE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Montpellier, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lapeyronie Hospital - CHU de Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>October 20, 2014</study_first_submitted>
  <study_first_submitted_qc>October 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 22, 2014</study_first_posted>
  <last_update_submitted>December 31, 2020</last_update_submitted>
  <last_update_submitted_qc>December 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Therapeutic education</keyword>
  <keyword>Functional insulin therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

